Navigation Links
Polymedco Aligns with MedPrimex to Fight Colorectal Cancer in Mexico
Date:8/30/2012

CORTLANDT MANOR, N.Y., Aug. 30, 2012 /PRNewswire/ -- Polymedco Cancer Diagnostic Products, LLC ("Polymedco CDP") is pleased to announce that a distribution agreement was signed with MedPrimex, LLC ("MedPrimex").  The agreement provides distribution rights, for the Mexican market, to MedPrimex for Polymedco CDP fecal immunochemical test (FIT) product line for screening for colorectal cancer (CRC).  Colorectal cancer is among the leading causes of cancer death worldwide, but nearly half of people who die failed to get screened.

Early detection and treatment dramatically increase chances of survival. Screening is the most realistic approach to reducing new cases by finding non-cancerous colorectal polyps and removing them before they become cancerous. 

The OC automated FIT and manual OC Light® tests are quick and easy screening methods that measure human hemoglobin in the patient's stool.  The tests can be performed at home with little disruption to the patient's daily routine – requiring only one sample collection and no changes to diet or medication. The higher specificity of FIT means that there are less false positive results.

"Our goal is to introduce the benefits of getting an annual screening using a fecal immunochemical test (FIT) to people of Mexico," said Drew Cervasio, President of Polymedco. "Innovations in screening have significantly improved the detection of breast, prostate and cervical cancers so it is time to pay attention to the advances that can drive more patients to find colorectal cancer earlier."

"Through these screening tests, we are better able to accurately identify at-risk patients and send more of the right patients for further evaluation and colonoscopy," said Ana Maria Pedroza, CEO of MedPrimex. "We are proud to be a part of an effort that will ensure citizens of our country will have access to the best options for their healthcare needs."

About Polymedco Cancer Diagnostic Products, LLC

Polymedco Cancer Diagnostic Products, LLC is a leading manufacturer, marketer, and distributer in the clinical laboratory marketplace. Polymedco supplies clinical diagnostic test kits and devices that are specialized in cancer. We are a world leader in non-invasive colorectal cancer screening technology, providing the new standard of care with the OC -Auto® product line. Since 1980, Polymedco has evolved into a highly skilled and successful marketing, sales, and manufacturing organization.

Combined with an experienced team of field representatives and strong technical service personnel, Polymedco Cancer Diagnostic Products provides a high level of customer, technical and reimbursement support. To reach Polymedco Inc. via the worldwide web, log on to www.polymedco.com.

About MedPrimex, LLC

MedPrimex is a trusted Mexican company specialized in providing medical equipment, early detection systems, and disease prevention to preserve the health of the Mexican population. MedPrimex has strong ties with lead companies to deliver innovative health system solutions and advance medical technology. MedPrimex goal is preserving the health and quality of life of people.

MedPrimex has unparalleled service, expertise, product, and service offerings — delivering solutions that are innovative and practical. MedPrimex focuses on what matters most - improving people's lives. MedPrimex strives to work for the success of their customers by providing exceptional value and superior service to best satisfy their needs.

To reach MedPrimex via the worldwide web, log on to www.medprimex.com.


'/>"/>
SOURCE Polymedco Cancer Diagnostic Products, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
2. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
3. Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
4. Makers Of Over-the-Counter Inhaler Leading Fight To Have Product Back On Market After Removal Due To Environmental Treaty
5. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
6. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
7. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
8. Janssen Biotech Announces Global License and Development Agreement for Investigational Anti-Cancer Agent Daratumumab
9. Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
10. Breast Cancer Diagnostic and Drug Technologies: Global Markets
11. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2017)... 2017 Janssen Biotech, Inc. (Janssen) announced today ... the U.S. Food and Drug Administration (FDA) for the ... the treatment of moderately to severely active rheumatoid arthritis ... are needed to further evaluate the safety of sirukumab ... "We are ...
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
Breaking Medicine Technology:
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
Breaking Medicine News(10 mins):